PAX3 and melanoma: Thus, PAX3, a well-known transcriptional regulator of MITF (Kubic et al., 2008), is upregulated during MAPKi treatment, which is also seen within 48 hr in a panel of BRAF mutant melanoma cell lines (Figure 2B).